BACKGROUND/AIM: The authors studied the expression of cancer stem cell surface marker, ABCG2, and neural stem cell marker, MCM2, in retinoblastoma and correlated clinicopathologically. METHODS: Among 39 retinoblastomas, 18 tumours were not subjected to preoperative/postoperative chemotherapy, 15 tumours underwent postoperative chemotherapy, and six tumours had preoperative chemotherapy. There were 20 tumours with no invasion and 19 tumours with invasion of choroid/optic nerve. ABCG2 and MCM2 expression was studied by immunohistochemistry. RESULTS: ABCG2 was positive in six of six and MCM2 was positive in five of six tumours that had recurred in the orbit or metastasised. ABCG2 was positive in 15/19 tumours with invasion. MCM2 was positive in 16/19 tumours with invasion. Invasive tumours showed higher expression of ABCG2 (p < 0.01) and MCM2 (p < 0.01) proteins. There was no correlation with differentiation and laterality of the tumours. Non-neoplastic retina was positive for ABCG2 and MCM2. CONCLUSION: ABCG2 and MCM2 were expressed more in invasive tumours. Further studies are needed to understand the significance of ABCG2 and MCM2 expression in retinoblastoma.
BACKGROUND/AIM: The authors studied the expression of cancer stem cell surface marker, ABCG2, and neural stem cell marker, MCM2, in retinoblastoma and correlated clinicopathologically. METHODS: Among 39 retinoblastomas, 18 tumours were not subjected to preoperative/postoperative chemotherapy, 15 tumours underwent postoperative chemotherapy, and six tumours had preoperative chemotherapy. There were 20 tumours with no invasion and 19 tumours with invasion of choroid/optic nerve. ABCG2 and MCM2 expression was studied by immunohistochemistry. RESULTS:ABCG2 was positive in six of six and MCM2 was positive in five of six tumours that had recurred in the orbit or metastasised. ABCG2 was positive in 15/19 tumours with invasion. MCM2 was positive in 16/19 tumours with invasion. Invasive tumours showed higher expression of ABCG2 (p < 0.01) and MCM2 (p < 0.01) proteins. There was no correlation with differentiation and laterality of the tumours. Non-neoplastic retina was positive for ABCG2 and MCM2. CONCLUSION:ABCG2 and MCM2 were expressed more in invasive tumours. Further studies are needed to understand the significance of ABCG2 and MCM2 expression in retinoblastoma.
Authors: Robert Folberg; Diva Salomao; Hans E Grossniklaus; Alan D Proia; Narsing A Rao; J Douglas Cameron Journal: Am J Surg Pathol Date: 2003-07 Impact factor: 6.394
Authors: M Maliepaard; G L Scheffer; I F Faneyte; M A van Gastelen; A C Pijnenborg; A H Schinkel; M J van De Vijver; R J Scheper; J H Schellens Journal: Cancer Res Date: 2001-04-15 Impact factor: 12.701
Authors: R W Robey; W Y Medina-Pérez; K Nishiyama; T Lahusen; K Miyake; T Litman; A M Senderowicz; D D Ross; S E Bates Journal: Clin Cancer Res Date: 2001-01 Impact factor: 12.531
Authors: M V Meng; G D Grossfeld; G H Williams; S Dilworth; K Stoeber; T W Mulley; V Weinberg; P R Carroll; T D Tlsty Journal: Clin Cancer Res Date: 2001-09 Impact factor: 12.531
Authors: Julio E Diestra; George L Scheffer; Isabel Català; Marc Maliepaard; Jan H M Schellens; Rik J Scheper; Jose R Germà-Lluch; Miguel A Izquierdo Journal: J Pathol Date: 2002-10 Impact factor: 7.996
Authors: T Litman; M Brangi; E Hudson; P Fetsch; A Abati; D D Ross; K Miyake; J H Resau; S E Bates Journal: J Cell Sci Date: 2000-06 Impact factor: 5.285
Authors: Carlos Rodriguez-Galindo; Mathew W Wilson; Guillermo Chantada; Ligia Fu; Ibrahim Qaddoumi; Célia Antoneli; Carlos Leal-Leal; Tarun Sharma; Margarita Barnoya; Sidnei Epelman; Louis Pizzarello; Javier R Kane; Ray Barfield; Thomas E Merchant; Leslie L Robison; A Linn Murphree; Patricia Chevez-Barrios; Michael A Dyer; Joan O'Brien; Raul C Ribeiro; John Hungerford; Eugene M Helveston; Barrett G Haik; Judith Wilimas Journal: Pediatrics Date: 2008-09 Impact factor: 7.124
Authors: Gail M Seigel; Abigail S Hackam; Arupa Ganguly; Lorrie M Mandell; Federico Gonzalez-Fernandez Journal: Mol Vis Date: 2007-06-08 Impact factor: 2.367